Gen-Probe Q4 Revenues Grow 16 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe's fourth-quarter revenues rose 16 percent year over year as its blood screening business rose 30 percent, the company said after the close of the market on Monday.

For the three months ended Dec. 31, 2011, the San Diego company posted revenues of $158.2 million, up from $136.7 million a year ago, just short of analyst estimates calling for $158.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.